Delivery Order SPE2DB20D1110-SPE2DB25FK03Q

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,255.79, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 14, 2023 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,682.52, is for the delivery of ELIQUIS 5 MG TABLET 60S, a medication used for various cardiovascular health conditions. The contract is a firm fixed-price arrangement with an ultimate completion date of August 30, 2022. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,976.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has a completion date of October 26, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,325.46, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 31, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,122.73, is for the delivery of ELIQUIS 5 MG TABLET 60S. The contract is a Firm Fixed Price type with a completion date of May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,125.80, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,464.92, is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 18, 2024 and is a firm fixed-price, Indefinite Delivery Contract (IDC) vehicle. The IDC, valued at $999,999,999, is the primary contracting mechanism...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,046.44, is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price, delivery order type with an ultimate completion date of November 15, 2023. This award is associated with AmerisourceBergen's larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,660.93, is for the supply of ELIQUIS 2.5 MG TABLET 60S, a cardiovascular medication. The contract is a firm-fixed price delivery order with a completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,804.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FK03Q
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,002.43, is for the delivery of ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The contract has a completion date of March 25, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 12:57 AM